The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain

Synapse

Volumn 68, Issue 2, 2014, Pages 45-60

  Danielson, Kirsty ^a   Putt, Fraser ^a   Truman, Penelope ^b   Kivell, Bronwyn M ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Addiction; Dopamine transporter; Norepinephrine transporter

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; DOPAMINE TRANSPORTER; MECAMYLAMINE; MONOAMINE TRANSPORTER; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN TRANSPORTER; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CORPUS STRIATUM; DOPAMINE UPTAKE; GENE EXPRESSION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARTICULATE MATTER; POTENTIOMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROTATING DISK ELECTRODE VOLTAMETRY; TOBACCO; TOBACCO PARTICULATE MATTER; VENTRAL TEGMENTUM;

ADDICTION; DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTER;

ACONITINE; ANIMALS; BRAIN; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC ANTAGONISTS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGAN SPECIFICITY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SMOKING; TOBACCO; TOBACCO SMOKE POLLUTION;

EID: 84890139702     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21715     Document Type: Article

References (50)

1. Ambrose V, Miller JH, Dickson SJ, Hampton S, Truman P, Lea RA, Fowles J. 2007. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells. Nicotine Tobacco Res 9:793-799.
2. Belluzzi JD, Wang RH, Leslie FM. 2005. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705-712.
3. Bitner RS, Nikkel AL. 2002. Alpha-7 nicotinic receptor expression by two distinct cell types in the dorsal raphe nucleus and locus coeruleus of rat. Brain Res 938(1-2):45-54.
4. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. 2007. D-2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71:1222-1232.
5. Carr LA, Rowell PP, Pierce WM. 1989. Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem Res 14:511-515.
6. Clemens KJ, Caille S, Stinus L, Cador M. 2009. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol 12:1355-1366.
7. Cox B, Kislinger T, Emili A. 2005. Integrating gene and protein expression data: Pattern analysis and profile mining. Methods 35:303-314.
8. Danielson K, Truman P, Kivell BM. 2011. The effects of nicotine and cigarette smoke on the monoamine transporters. Synapse 65:866-879.
9. Database Systematic Review (1):77.
10. Dichiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
11. Dichiara G, Tanda GL, Frau R, Carboni E. 1992. Heterologous monoamine reuptake-Lack of specificity of neuron-specific carriers. Neurochem Int 20:S231-S235.
12. Drew AE, Derbez AE, Werling LL. 2000. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse 38:10-16.
13. Drew AE, Werling LL. 2003. Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine. Schizophrenia Res 65:47-55.
14. Earles C, Wayment H, Green M, Schenk JO. 1998. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: Methodology and mechanistic interpretations. Neurotransmitter Transporters 296:660-675.
15. Foddai M, Dosia G, Spiga S, Diana M. 2004. Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology 29:530-536.
16. Green TA, Crooks PA, Bardo MT, Dwoskin LP. 2001. Contributory role for nornicotine in nicotine neuropharmacology: Nornicotine-evoked [H-3]dopamine overflow from rat nucleus accumbens slices. Biochem Pharmacol 62:1597-1603.
17. Hadjiconstantinou M, Duchemin AM, Zhang HL, Neff NH. 2010. Enhanced dopamine transporter function in striatum during nicotine withdrawal. Synapse 65:91-98.
18. Hara K, Harris RA. 2002. The anesthetic mechanism of urethane: The effects on rotransmitter-gated ion channels. Anesthesia Analgesia 94:313-318.
19. Hart C, Ksir C. 1996. Nicotine effects on dopamine clearance in rat nucleus accumbens. J Neurochem 66:216-221.
20. Herraiz T, Chaparro C. 2005. Human monoamine oxidase is inhibited by tobacco smoke: Beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378-386.
21. Hurley LL, Taylor RE, Tizabi Y. 2012. Positive and negative effects of alcohol and nicotine and their interactions: A mechanistic review. Neurotoxicity Res 21:57-69.
22. Itoh H, Toyohira Y, Ueno S, Saeki S, Zhang H, Furuno Y, Takahashi K, Tsutsui M, Hachisuka K, Yanagihara N. 2010. Upregulation of norepinephrine transporter function by prolonged exposure to nicotine in cultured bovine adrenal medullary cells. Naunyn-Schmiedebergs Arch Pharmacol 382:235-243.
23. Izenwasser S, Cox BM. 1992. Inhibition of dopamine uptake by cocaine and nicotine-Tolerance to chronic treatments. Brain Res 573:119-125.
24. Izenwasser S, Jacocks HM, Rosenberger JG, Cox BM. 1991. Nicotine indirectly inhibits [H-3] dopamine uptake at concentrations that do not directly promote [H-3] dopamine release in rat striatum. J Neurochem 56:603-610.
25. Janhunen S, Ahtee L. 2007. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development. Neurosci Biobehav Rev 31:287-314.
26. Khalki H, Navailles S, Piron CL, De Deurwaerdere P. 2013. A tobacco extract containing alkaloids induces distinct effects compared to pure nicotine on dopamine release in the rat. Neuroscience Lett 544:85-88.
27. Kile BM, Walsh PL, McElligott ZA, Bucher ES, Guillot TS, Salahpour A, Caron MG, Wightman RM. 2012 Optimizing the temporal resolution of fast-scan cyclic voltammetry. ACS Chem Neurosci 18;3:285-292.
28. Le Foll B, Chefer SI, Kimes AS, Shumway D, Stein EA, Mukhin AG, Goldberg SR. 2009. Baseline expression of alpha 4 beta 2*nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. Biol Psychiatry 65:714-716.
29. Markou A, Paterson NE. 2001. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 3:361-373.
30. Middleton LS, Apparsundarain S, King-Pospisil KA, Dwoskin LP. 2007a. Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism. Eur J Pharmacol 554(2-3):128-136.
31. Middleton LS, Cass WA, Dwoskin LP. 2004. Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex. J Pharmacol Exp Therapeutics 308:367-377.
32. Middleton LS, Crooks PA, Wedlund PJ, Cass WA, Dwoskin LP. 2007b. Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Synapse 61:157-165.
33. Miller LR, Mukherjee S, Ansah TA, Das SK. 2007. Cigarette smoke and dopaminergic system. J Biochem Mol Toxicol 21:325-335.
34. Nisell M, Nomikos GG, Hertel P, Panagis G, Svenssom TH. 1996. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 22:369-381.
35. Parish CL, Nunan J, Finkelstein DI, McNamara FN, Wong JY, Waddinton JL, Brown RM, Lawrence AJ, Home MK, Drago J. 2005. Mice lacking the α4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. Mol Pharmacol 68:1376-1386.
36. Povlock SL, Schenk JO. 1997. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J Neurochem 69:1093-1105.
37. Rahman S, Zhang J, Engleman EA, Corrigalla WA. 2004. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: A microdialysis study. Neuroscience 129:415-424.
38. Rose JE, Salley A, Behm FM, Bates JE, Westman EC. Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. 2010. Psychopharmacology 210:1-12.
39. Salas R, De Biasi M. 2008. Opposing actions of chronic stress and chronic nicotine on striatal function in mice. Neurosci Lett 440:32-34.
40. Scholze P, Orr-Urtreger A, Changeux JP, McIntosh JM, Huck S. 2007. Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation. Br J Pharmacol 151:414-422.
41. Shepard JD, Chuang DT, Shaham Y, Morales M. 2006. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology 185:505-513.
42. Tizabi Y, Bai L, Copeland RL, Taylor RE. 2007. Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell. Alcohol Alcoholism 42:413-416.
43. Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R. 2007. Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. Neuroreport 18:925-929.
44. Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM. 2007. Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52:1415-1425.
45. Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE. 2009. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K+-stimulated dopamine release in frozen rat brain tissue. J Neurosci Methods 180:317-320.
46. Watkins SS, Epping-Jordan MP, Koob GF, Markou A. 1999. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743-751.
47. Weisinger G, Gavish M, Mazurika C, Zinder O. 1999. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: Tissue- and treatment-specificity. Biochimica Et Biophysica Acta-Gene Structure Expression 1446:225-232.
48. WHO 2011. Tobacco Fact Sheet No 339.: World Health Organisation.
49. Yamashita H, Kitayama S, Zhang YX, Takahashi T, Dohi T, Nakamura S. 1995. Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and PC12 cells. Biochem Pharmacol 49:742-745.
50. Zhu J, Apparsundaram S, Dwoskin LP. 2009. Nicotinic receptor activation increases [H-3]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex. J Pharmacol Exp Therapeutics 328:931-939.